Press Releases

FRISCO, Texas, Aug. 8, 2019 /PRNewswire/ -- Millie Sukkar, APRN, FNP-BC, with Men's T Clinic is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

TUCSON, Ariz., Aug. 8, 2019 /PRNewswire/ -- Peter Burrows, MD with Arizona Center for Vasectomy and Urology is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- John Salerno, MD, DO with The Salerno Center is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED). This cutting-edge procedure boasts a 75% success rate amongst patients. The treatment is called

INDIANAPOLIS, Aug. 8, 2019 /PRNewswire/ -- Capturing objective data in about five seconds that can aid concussion diagnoses through an iPhone, the Reflex PLR Analyzer, an industry-disruptive diagnostic tool for traumatic brain injury (TBI) and various cognitive issues, is rapidly advancing in the healthcare market. As brightlamp's premier mobile pupillometer tech

HOUSTON, Aug. 8, 2019 /PRNewswire/ -- MolecularMatch, a leading clinical informatics company providing Precision Medicine software solutions for oncology, announced today that the United States Patent and Trademark Office has issued US Patent 10,360,349 covering its Precision Medicine Service for use by hospitals, pharmaceutical companies, laboratories, h

CHARLOTTE, N.C., Aug. 8, 2019 /PRNewswire/ -- cbdMD, Inc., a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), celebrates the second annual National CBD Day. This day is observed on August 8th and was founded by cbdMD in 2018.

KANSAS CITY, Mo., Aug. 8, 2019 /PRNewswire/ -- CRB is excited to announce the promotion of Joshua Miksch, PE to a team leader role for CRB's Boston office.

SAN FRANCISCO, and HERZLIYA, Israel, Aug. 8, 2019 /PRNewswire/ -- 89Bio Ltd. (89bio), a clinical-stage biopharmaceutical company, today announced that the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its investigational product candidate, BIO89-100, a glycoP

TORONTO, Aug. 8, 2019 /PRNewswire/ -- DW Healthcare Partners ("DWHP"), a healthcare-focused private equity firm, announced today a majority investment in CEFALY Technology SPRL ("CEFALY"), a leading global manufacturer and marketer of neuro-modulating medical devices for the prevention and treatment of migraines. CEFALY is the first investment in

BIRMINGHAM, Ala., Aug. 8, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Baird Global Healthcare Conference in New York City and the Wells Fargo Securities Healthcare Conference in Boston. Both conferences will occur Sept. 4-5